Coronary Microvascular Function and CT Coronary Angiography (CorCTCA) (CorCTCA)
Angina, Stable, Angina Pectoris, Variant, Microvascular Angina
About this trial
This is an interventional diagnostic trial for Angina, Stable
Eligibility Criteria
Inclusion Criteria:
- Symptoms of angina or angina-equivalent informed by the Rose Angina questionnaire.
- Intermediate or no obstructive coronary disease i.e. no coronary stenosis >70% in an artery >2.5 mm, as revealed by CT coronary angiography.
Exclusion Criteria:
- A health problem that would explain the angina, e.g. anaemia, moderate-severe aortic stenosis, hypertrophic obstructive cardiomyopathy
- Obstructive disease evident in a coronary artery (diameter >2.5 mm), i.e. >50 - 70% circumferential plaque extending for ≥2 coronary segments, or a stenosis>70% as revealed by CT coronary angiography
Lack of informed consent.
Exclusion from randomisation in the catheter laboratory:
- Flow-limiting coronary disease defined by a fractional flow reserve (FFR) ≤0.80 in an artery>2.5 mm.
Sites / Locations
- Golden Jubilee National Hospital
- Forth Valley Royal Hospital
- Glasgow Royal Infirmary
Arms of the Study
Arm 1
Arm 2
Active Comparator
Sham Comparator
Intervention group (coronary function test results disclosed)
Usual care group (coronary function results not disclosed)
Coronary function tests are measured and disclosed to the clinician for re-evaluation of the initial diagnosis and treatment as compared with initial angiography. The intervention involves measurement of FFR, CFR, IMR and RRR in a major coronary artery followed by reactivity testing using incremental doses of acetylcholine (10-4 Molar (M), 10-5 M, 10-6 M) to assess endothelial function, bolus of ACh (10-4 M; 100 micrograms) for vasospasm, followed by glyceryl trinitrate (300 micrograms). FFR will be measured in all arteries with a diameter >=2.5 mm and a stenosis 40% to 90% in severity. Endotypes are based on criteria for abnormal coronary vasodilator function, vasospasm and microvascular resistance. The endotypes (diagnostic strata) are: obstructive CAD, vasospastic angina, microvascular angina, mixed (ie both vasospastic and microvascular disorders), endothelial dysfunction (no angina), normal (non-cardiac). A diagnosis may be ruled-in or ruled-out based on the test results.
Coronary function tests are measured but not disclosed to the attending clinician or the participant. The same coronary function tests are undertaken as in the intervention group. Masking is achieved by obscuring the catheter laboratory monitors from the attending clinician and participant. The effectiveness of masking and protocol adherence is prospectively monitored.